| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
31,670,000 |
| Market
Cap: |
5.38(B) |
| Last
Volume: |
1,282,655 |
Avg
Vol: |
581,994 |
| 52
Week Range: |
$169.81 - $169.81 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Home Health Care |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile LHC Group is a holding company. Through its subsidiaries, Co. provides post-acute health care services to its patients. Co.'s segments include: home health services, which include nursing, medically-oriented social services and physical, occupational, and speech therapy; hospice services, which include pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, and family bereavement counseling; and home and community-based services, which include assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Proffitt Joshua L. |
Chief Financial Officer |
• – – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,550 |
91,575 |
|
- |
|
| Fontenot Teri G. |
Director |
– • – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
5,800 |
|
- |
|
| Greenstein Bruce D |
Chief Innovation Officer |
• – – |
2020-03-01 |
4 |
D |
$121.46 |
$29,636 |
D/D |
(244) |
18,647 |
|
- |
|
| Greenstein Bruce D |
Chief Innovation Officer |
• – – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,690 |
18,891 |
|
- |
|
| Mcquiddy Collin |
SVP, Chief Accounting Officer |
– – – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
480 |
480 |
|
- |
|
| Nixon Ronald T |
Director |
– • – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
30,200 |
|
- |
|
| Reed W Earl Iii |
Director |
– • – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
113,749 |
|
- |
|
| Goldberg Jonathan |
Director |
– • – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
48,694 |
|
- |
|
| Indest John L |
Director |
– • – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
2,472 |
|
- |
|
| Holtz Clifford S |
Director |
– • – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
6,623 |
|
- |
|
| Myers Keith G |
CEO and Chairman |
• • – |
2020-03-01 |
4 |
D |
$121.46 |
$2,786,414 |
D/D |
(22,941) |
70,114 |
|
- |
|
| Myers Keith G |
CEO and Chairman |
• • – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
19,220 |
93,055 |
|
- |
|
| Gachassin Nicholas Iii |
EVP, General Counsel |
• – – |
2020-01-01 |
4 |
D |
$137.76 |
$33,889 |
D/D |
(246) |
3,239 |
|
- |
|
| Myers Keith G |
CEO and Chairman |
• • – |
2019-11-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
7,500 |
324,746 |
|
- |
|
| Myers Keith G |
CEO and Chairman |
• • – |
2019-11-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,400 |
332,246 |
|
- |
|
| Proffitt Joshua L. |
Chief Financial Officer |
• – – |
2019-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
13,580 |
77,025 |
|
- |
|
| Myers Keith G |
CEO and Chairman |
• • – |
2019-08-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
333,646 |
|
- |
|
| Proffitt Joshua L. |
Executive Vice President |
• – – |
2019-08-01 |
4 |
D |
$123.51 |
$310,504 |
D/D |
(2,514) |
63,445 |
|
- |
|
| Nguyen Tricia |
EVP, Chief Medical Officer |
– – – |
2019-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,150 |
4,150 |
|
- |
|
| Greenstein Bruce D |
Chief Innovation Officer |
• – – |
2019-08-01 |
4 |
D |
$123.51 |
$41,870 |
D/D |
(339) |
11,201 |
|
- |
|
| Goldberg Jonathan |
Director |
– • – |
2019-07-19 |
4 |
A |
$122.84 |
$1,965 |
I/I |
16 |
16 |
|
- |
|
| Goldberg Jonathan |
Director |
– • – |
2019-07-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
16 |
48,678 |
|
- |
|
| Stelly Donald Dwayne |
President & COO |
• – – |
2019-06-12 |
4 |
S |
$115.87 |
$383,066 |
D/D |
(3,306) |
98,267 |
|
- |
|
| Indest John L |
Director |
– • – |
2019-06-06 |
4 |
S |
$113.76 |
$3,471,386 |
D/D |
(30,515) |
22,947 |
|
- |
|
| Stelly Donald Dwayne |
President & COO |
• – – |
2019-06-01 |
4 |
D |
$113.28 |
$305,176 |
D/D |
(2,694) |
101,573 |
|
- |
|
461 Records found
|
|
Page 5 of 19 |
|
|
